Shares of MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) were up 0.2% on Wednesday . The company traded as high as $0.40 and last traded at $0.39. Approximately 420,793 shares changed hands during mid-day trading, an increase of 214% from the average daily volume of 134,123 shares. The stock had previously closed at $0.39.
MyMD Pharmaceuticals Stock Down 6.1 %
The company has a fifty day moving average of $0.71 and a two-hundred day moving average of $1.16.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Articles
- Five stocks we like better than MyMD Pharmaceuticals
- The How And Why of Investing in Oil Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is Insider Trading? What You Can Learn from Insider Trading
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is a buyback in stocks? A comprehensive guide for investors
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
